Europe Pulse Oximeters Market Size, Share & Industry Analysis, By Product Type (Fingertip Oximeters, Handheld Oximeters, Tabletop Oximeters, and Others), By Technology (Conventional, and Smart), By Age Group (Adults and Pediatrics), By Area of Care (Hospitals / Acute Care [ICU, Operating Rooms & Post-Anesthesia Care Units, and Emergency Departments], Ambulatory & Outpatient Care [Primary Care Clinics, and Specialty Clinics], Homecare / Remote Monitoring, and Prehospital / EMS Ambulance Services), and Country Forecast, 2025-2032

The Europe pulse oximeters market size was valued at USD 937.8 million in 2024. The market is projected to grow from USD 957.7 million in 2025 to USD 1,313.9 million by 2032, exhibiting a CAGR of 4.6% during the forecast period.

Pulse oximeters are a small, non-invasive device that measures the oxygen saturation level (SpO2) in the red blood cells. The growing prevalence of chronic respiratory diseases, including asthma, chronic obstructive pulmonary disorder (COPD), and others, is resulting in a rising number of hospital admissions, further contributing to the demand for these products in the region. Furthermore, increasing aging population is also a vital factor, supporting the prevalence of respiratory diseases in the region. Growing prevalence and patient admissions, along with technological advancements, are augmenting the demand for these devices, thereby boosting its adoption rate in Europe.

Moreover, the market players, including Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Masimo, Medtronic, GE Healthcare, and others, are focusing on research and development activities to develop and introduce technologically advanced products, and thus are expected to contribute to the market share.

MARKET DYNAMICS

MARKET DRIVERS

Technological Advancements in Pulse Oximeters are Anticipated to Propel Market Growth

The growing investment by prominent players in the development of technologically advanced pulse oximeters is one of the vital factor boosting the use of pulse oximeters by improving accuracy, expanding applications, and creating new product categories. Technologically advanced devices are integrated with multi-wavelength and reflectance sensors, enabling reliable and accurate readings across low perfusion conditions among the patient population.

• In August 2021, Masimo received CE marking approval and launched Masimo SafetyNet Alert, an arterial blood oxygen saturation monitoring and alert system designed for use at home with the aim of increasing its brand presence in Europe.

The emergence of miniaturized or low-power sensors enables their incorporation into wearable devices such as wristbands, patches, rings, and others for continuous monitoring of chronic diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, and others. Additionally, the integration of Bluetooth, telehealth compatibility, and cloud integration has transformed the pulse oximeters from standalone units into components of the digital health ecosystem.

The increasing benefits of technologically advanced pulse oximeters are augmenting the demand for these products. This is also driving the focus of key players toward research and development activities to develop and introduce novel products, thereby contributing to Europe pulse oximeters market growth.

Other Prominent Drivers

• Post-COVID awareness & preparedness: The pandemic increased general awareness of oxygen saturation monitoring; many institutions and consumers now view pulse oximetry as essential component, thus boosting the product adoption in the market.
• Regulatory and screening mandates: Some countries may adopt screening protocols, such as congenital heart disease screening in newborns using pulse oximetry, therefore contributing to the enhanced penetration rate of the products.
• Renewal cycles and hospital upgrades: Healthcare facilities periodically upgrade diagnostic and monitoring equipment to adopt newer models with better features, which encourages replacement demand, thus, fueling the need for pulse oximetry solutions.

MARKET RESTRAINTS

Inaccuracies and Limitations Associated with Use of Pulse Oximeters Hinders Product Adoption

Despite the growing adoption of pulse oximeter products, one of the major obstacle to market growth is the inaccuracies associated with these devices. Various factors affect the functioning of pulse oximetry products, including skin temperature, poor circulation, current tobacco use, skin thickness, dark skin pigmentation, and use of fingernail polish.

Pulse oximeters have a higher error rate in black patients. Many studies have shown that these products result in misleading readings among African-American patients.

• For instance, according to another study published by the Children’s Hospital of Philadelphia (CHP) in March 2023, it was found that 12% of patients with dark skin pigmentation with true low oxygen levels had a “normal” pulse oximetry measurement as compared with 4% in the white population among 774 respondents, including 201 black of African-American patients and 573 white patients.

MARKET OPPORTUNITIES

Increasing Number of Partnerships & Acquisitions to Augment the Market Expansion

There is a growing prevalence of chronic conditions resulting in an increasing number of admissions in healthcare settings. A growing number of patient admissions, along with a surging healthcare facilities, is likely to augment the demand for these pulse oximetry solutions.

Furthermore, the prominent players are emphasizing acquisitions and collaborations among other players in the industry with an aim to cater to growing demand for the product. The increasing number of collaborations and acquisitions among the key players and sensor technology companies, digital health platforms, and medical device firms is anticipated to create opportunities by enabling the incorporation of pulse oximetry solutions into telehealth solutions and remote patient monitoring systems.

• In September 2025, Koninklijke Philips N.V., with Masimo, renewed their multi-year strategic collaboration with an aim to accelerate the development and delivery of next-generation patient monitoring solutions to expand access to high-quality, connected care among clinicians. This partnership integrates Masimo’s advanced monitoring technologies – including SET pulse oximetry, Radius PPG, and a range of sensor technology – into Philips’ multi-parameter patient monitoring platforms.

MARKET CHALLENGES

Limited Reimbursement Policies to Hamper Market Growth

One of the vital factors hampering the market growth is the limited reimbursement policies for these devices in the home care settings. The region’s reimbursement scenario is stringent, and devices intended for home use must demonstrate cost-effectiveness, clinical utility, and fit into existing reimbursement codes and categories, which subsequently increases the out-of-pocket expenses among the patient population.

• For instance, according to 2021 statistics published by the Medicines and Healthcare Products Regulatory Agency (MHRA), home use of these pulse oximetry solutions is only recommended if they are advised by a qualified clinician and used under clinical review. Therefore, stringent guidelines for use and reimbursement of these devices in home care settings are likely to hamper their adoption rate in the market.

Other Prominent Challenges

• Regulations & clinical validation requirements: Medical device approval, CE marking, clinical trials, compliance, and regulatory oversight in Europe raise the bar for new entrants.
• Competition from alternatives/integrated devices: Some wearable devices or multiparameter monitors embed SpO2 sensors, reducing demand for stand-alone oximeters.
• Supply chain/component cost pressures: Sensor component costs, supply risk for optical parts, semiconductors, and assembly pressures can constrain margins.
• Market saturation in mature segments: In developed European markets, most of the hospital infrastructure already has baseline oximetry—future growth depends more on upgrades and home segments.

EUROPE PULSE OXIMETERS MARKET TRENDS

Increasing Adoption of Pulse Oximeters in Homecare Settings is an Emerging Trend

There is an increasing preference toward the adoption of these pulse oximeters in home care settings due to its rising advantages, including continuous monitoring of blood oxygen levels, easy detection of hypoxemia, and others. Increasing demand for these devices in home care settings is resulting in a growing focus of major players toward developing and launching technologically advanced pulse oximetry devices for home care settings. Moreover, improvements in reimbursement policies and expansion of telehealth and remote patient monitoring solutions are expected to boost the penetration rate for clinical-grade pulse oximetry solutions for use at home.

• In May 2024, Owlet Inc., received medical device certification from the European Union for its Dream Sock, an over-the-counter pulse rate and oxygen saturation monitor for routine in-home monitoring among infants. The company is planning to launch this product in Germany, France, and U.K., with further expansion to other European countries after receiving the product approval.

Other Prominent Trends

Adoption of Wearable Pulse Oximeters: Growth of wearable pulse oximeters/wrist-based/ring-based SpO₂ sensors, integrating into fitness trackers or health monitoring suites.

Download Free sample to learn more about this report.

Segmentation Analysis

By Product Type

Growing Prevalence of Respiratory Diseases Led to Tabletop Oximeters Segmental Growth

Amongst product type, the market is divided into fingertip oximeters, handheld oximeters, tabletop oximeters, and others.

To know how our report can help streamline your business, Speak to Analyst

The tabletop oximeters segment held the highest Europe pulse oximeters market share in 2024. This growth is due to increasing prevalence of respiratory diseases and rising geriatric population, resulting in a growing number of patient admissions in healthcare settings such as hospitals and others. Tabletop oximeters are mainly used in highest-value clinical settings owing to their benefits, such as high accuracy, continuous blood glucose monitoring, among others. Along with this, the regulatory scenario and reimbursement policies also emphasize clinical-grade devices for hospital use, further supporting the demand for pulse oximeters in the market. On the other hand, fingertip oximeters are expected to grow with a considerable CAGR during the forecast period.

• For instance, according to 2024 statistics published by the Asthma + Lung U.K., approximately 7.2 million people have Asthma across U.K.

The fingertip pulse oximeters segment is expected to grow at a CAGR of 5.9% during the forecast period.

By Technology

Growing Adoption Rate Led to Dominance of Conventional Segment

Amongst technology, the market is bifurcated into conventional and smart.

The conventional segment captured largest share of the market in 2024. In 2025, the segment is expected to dominate with a 68.2% of share. Benefits associated with the conventional oximeters, such as cost-effectiveness, established technology, widespread availability, among others, are resulting in growing installed bases for these devices in healthcare settings. This, along with improved regulatory policies and reimbursement scenarios, is further contributing to the rising adoption and demand of such conventional oximeters in the market.

• For instance, according to a 2022 study published by Springer Nature, it was reported that conventional pulse oximetry solutions showed 85.7% of sensitivity for critical congenital heart issues among the patients in healthcare settings.

The smart segment is expected to grow at a CAGR of 5.0% during the forecast period.  

By Age Group

Increasing Prevalence of Respiratory Conditions Among Adults to Drive Segment Growth

Based on age group, the market is segmented into adults and pediatrics.

The adults segment held the dominating position in 2024 with a share of 85.8%. This growth is attributed to the increasing prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and others, resulting in a growing number of hospital admissions in healthcare settings. This, along with growing adoption of oximeters in home care settings for routine monitoring among patients, is further expected to boost the adoption rate of these products in the market.

• For instance, according to the 2023 article published by the National Center for Biotechnology Information (NCBI), it was reported that the prevalence of asthma ranges from 5.1% to 8.2% in adults in Europe.

The segment of pediatrics is set to flourish with a growth rate of 4.2% growth across the forecast period.

By Area of Care

Growing Number of Hospitals /Acute Care Settings Drives Segment Dominance

Amongst the areas of care, the market is segmented into hospitals / acute care, ambulatory & outpatient care, homecare / remote monitoring, and prehospital/EMS ambulance services. The hospitals / acute care segment is further divided into ICU, operating rooms & post-anesthesia care units, and emergency departments. The ambulatory & outpatient care segment is sub-classified into primary care clinics and specialty clinics. The homecare / remote monitoring is divided into chronic disease management, post-discharge monitoring, and telehealth / remote patient monitoring platforms.

The hospitals / acute care segment dominated the market in 2024. The growth is primarily due to increasing number of patient admissions for various respiratory diseases, along with the growing number of healthcare facilities, such as hospitals, in Europe. The growing prevalence and increasing advancement in pulse oximeters are expected to drive the demand for this equipment, further supporting the segmental growth.

• For instance, according to 2025 statistics published by Statistisches Bundesamt, there are about 1,874 hospitals in Germany.

In addition, homecare / remote monitoring area of care are projected to grow at a CAGR of 5.4% during the study period.

Europe Pulse Oximeters Market Country Outlook

Increasing Healthcare Expenditure Supported the Country’s Dominance

Based on country/sub-region, the market is divided into the U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe.

Germany dominated the market in 2024. The increasing per capita healthcare expenditure, rising incidence of respiratory disorders, and growing number of installed bases for these products are few factors contributing to the increasing adoption rate for pulse oximeters in the market. This, along with an increasing focus of key players toward acquisitions and mergers among the other players to increase their brand presence and launch innovative pulse oximeters, are expected to further boost the market growth.

• For instance, according to the 2021 statistics published by the Statistisches Bundesamt, the healthcare expenditure was about USD 513.0 billion in Germany.

In addition, the U.K. is projected to grow at a CAGR of 5.9% during the study period.

COMPETITIVE LANDSCAPE

Key Industry Players

Increasing Number of Product Offerings Among Prominent Players Supported Their Dominance

The market shows a semi-consolidated structure with numerous small- to mid-size players actively operating in the industry.

Koninklijke Philips N.V., dominated the Europe market in 2024. The strong focus of the company on acquisitions and collaborations is one of the major reasons supporting the growth of the company in the market.

• In June 2023, Koninklijke Philips N.V., collaborated with Masimo and received U.S. Food and Drug Administration approval for Sedline brain function monitoring, regional oximetry (O3), and CO₂ measurements in Philips patient monitors – IntelliVue MX750 and MX850, with an aim to help clinicians make quick and informed decisions without the need for additional monitoring equipment.

Apart from this, other prominent players in the market include Masimo, Medtronic, GE Healthcare, and others. These companies are focusing on research and development investments to strengthen their brand presence, thereby contributing to their market share in the region.

LIST OF KEY PULSE OXIMETERS COMPANIES PROFILED

• GE Healthcare (U.S.)
• Masimo (U.S.)
• Drägerwerk AG & Co. KGaA (Germany)
• Nonin (U.S.)
• Medtronic (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• ICU Medical, Inc. (U.S.)
• Beurer GmbH (Germany)
• NIHON KOHDEN CORPORATION (Japan)
• OMRON Corporation (Japan)

KEY INDUSTRY DEVELOPMENTS

• August 2025: Drägerwerk AG & Co. KGaA received the company’s Authority to Operate (ATO) certification for the Atlan A350/A350 XL series of anesthesia workstations, which provides highest level of patient data security for medical devices. This helped the company increase its brand presence.
• July 2024: Koninklijke Philips N.V., collaborated with Bon Secours Mercy Health (BSMH), one of the nation’s largest Catholic health systems, with an aim to improve its product offerings for patient monitoring.
• June 2023: Beurer GmbH established a new subsidiary in the Netherlands, based in Amsterdam, with an aim to expand its sales and service structure for the countries of Belgium, the Netherlands, and Luxembourg to serve the European market.
• November 2022: Beurer GmbH collaborated with Medisanté to connect and manage its new Internet of Things (IoT) devices over a private cellular network for remote patient monitoring (RPM) and decentralized clinical trials (DCT) with an aim to strengthen its product offerings.
• February 2021: Medtronic announced the results of an observational study comparing the reliability and efficacy of two pulse oximeters — Nellcor Bedside SpO2 Patient Monitoring System and Masimo Radical-7 Pulse Co-Oximeter. This helped the company increase its brand presence.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation